Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Article | IMSEAR | ID: sea-200880

ABSTRACT

Introduction: The aim of the present study was to compare two immobilization systems for comparison of setup errors in targeted radiotherapy. Methods: Retrospective analysis was done for the patients undergoing radiotherapy from May 2012 to December 2018 at our institution. Immobilization was performed on 30 patients sessions (Vacuum cushion i.e., Vac-Lok™ = 15; Thermoplastic mould i.e., Pelvicast pelvic masks = 15). A total of 763 cone-beams were analysed. The target lesion location was verified by cone-beam computed tomography (CBCT) prior to each session, with displacements assessed by CBCT simulation prior to each treatment session. Systematic setup errors, random setup errors, isocenter deviations in the Medio-lateral (ML), Supero-inferior (SI), Antero-posterior (AP), Rotation (yaw) directions of the patient position was calculated. Results: On comparing the Vac-Lok™ and Pelvicast pelvic masks group with respect to Systematic and random error in the lateral, longitudinal, vertical and YAW direction, no statistically significant difference was seen except the random error in YAW direction (P=0.037, Unpaired t-test). There was no difference observed in comparing the isocentric deviation. Conclusion: It was inferred and concluded that using a vacuum cushion for pelvic radiotherapy provides no added benefit compared to using a thermoplastic mould. Thermoplastic mould is recommended for patients receiving pelvic radiotherapy to improve overall reproducibility

2.
The Journal of Practical Medicine ; (24): 3966-3971, 2017.
Article in Chinese | WPRIM | ID: wpr-665469

ABSTRACT

Objective To evaluate the safety of cyclosporine(CsA)and methotrexate(MTX)in the treat-ment of psoriasis and to analyze the risk factors of side effects in the course of treatment. Methods In this retro-spective study,the patients with psoriasis treated with CsA and MTX were enrolled from April 2012 to April 2016 in Hainan Province. The clinical data and medication status of the patients were retrospectively collected. All pa-tients underwent laboratory tests such as blood,liver enzyme,renal function,and urine tests before treatment and during the follow-up. During the course of the study,any adverse events were recorded in the rotation treatment. Results A total of 42 psoriatic patients were enrolled. After screening,42 patients with psoriasis were enrolled. The average dosage and cumulative dose were(456.79 ± 472.14)days,and(134.68 ± 183.24)g for cyclosporine and(274.51 ± 215.32)days,(418.62 ± 435.63)mg for methotrexate.Four patients had abnormal laboratory tests after treatment:4 patients(9.5%)had abnormal transaminases and 2(4.8%)were accompanied by abnormal uric acid. The renal function tests(serum creatinine and blood urea nitrogen),blood cell count and urine tests for all patients were in the normal range. Conclusions In the long-term systemic treatment of chronic plaque psoriasis, the use of cyclosporine A and methotrexate therapy can largely reduce the side effects of drugs,especially the oc-currence of renal toxicity. In the course of treatment,the epidemiology of patient,duration of disease,severity of the disease,the dose and duration of drugs are not high risk factors for the side effects of drugs.

SELECTION OF CITATIONS
SEARCH DETAIL